Japan· JP-2329024F2021
ミソプロストール
A misoprostol product containing ミソプロストール, registered in Japan by ファイザー, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Misoprostol is registered in 11 of 19 countries.
Countries holding a registration under ATC A02BB01 (misoprostol), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 6 of them publish a price we can compare per daily dose
Misoprostol · ATC A02BB01
11 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of misoprostol costs, country by country.
Normalised to the WHO defined daily dose (0.8 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Misoprostol · price per daily dose (0.8 mg)
USD · FX 28 Sept 2026
- CH Switzerland$3.14
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ミソプロストール
- Manufacturer
- ファイザー
- Country
- Japan (JP)
- ATC code
- A02BB01
- ATC class
- Misoprostol
- Defined daily dose
- 0.8 mg, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
246 interactions on record for misoprostol.
Graded by severity as the source publishes them — 10 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Misoprostol · interactions on record
246 records
- 10 moderate
- 6 minor
- 229 info
Most severe, free to view
- Magnesium carbonateA02AA01moderate
- Magnesium oxideA02AA02moderate
- Magnesium hydroxideA02AA04moderate
- Kombinationen von AluminiumsalzenA02AB10moderate
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under A02BB01
Misoprostol, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f0396378-f4b0-4beb-b348-9e5f6f6102c0 GET /v1/drugs/f0396378-f4b0-4beb-b348-9e5f6f6102c0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１００μｇ１錠",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "2329024F2021",
"category": "内用薬",
"price_yen": 9.6,
"generic_name": "ミソプロストール",
"product_name_jp": null,
"therapeutic_class": "2329",
"transitional_expiry": null
}See everything about misoprostol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.